Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan.
Location: Switzerland, Zurich, Schlieren
Employees: 11-50
Founded date: 2019
Investors 6
| Date | Name | Website |
| - | Purpose Ve... | purposeven... |
| - | What If Ve... | whatif.vc |
| - | Korify Cap... | korifycapi... |
| - | QC·VENTURE... | qc-venture... |
| - | Catalio Ca... | cataliocap... |
| - | p53 | p53.no |
Mentions in press and media 1
| Date | Title | Description |
| 13.12.2021 | Rejuveron Increases to Near-majority Stake in Endogena Through Funding $20 Million to Progress Treatments for Degenerative Diseases of the Eye | Rejuveron Life Sciences AG, a Zürich-based biotechnology company developing technologies for healthy aging, announced that it has strengthened its support to a near-majority holding in Endogena Therapeutics Inc., an endogenous regenerative ... |